MedPath

The Effectiveness of Flashforward EMDR Treatment for patients with an ICD

Conditions
anxiety
10007521
10002861
Registration Number
NL-OMON56774
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
33
Inclusion Criteria

Participants have anxiety symptoms related to their ICD.

Exclusion Criteria

Severe psychatric disorders that warrant (other)psychiatric treatment first.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To assess the disease specific anxiety levels of the participants, the patients<br /><br>will fill out the Cardiac Anxiety Questionnaire (CAQ). The CAQ is a self-report<br /><br>questionnaire consisting of 18 items, divided in three subscales (fear: 8,<br /><br>avoidance: 5, and attention: 5) created to measure heart-focussed anxiety.<br /><br>Patients rate every item on a 5-point Likert scale, ranging from 0 (never) to 4<br /><br>(always). The score per subscale is calculated as the mean per subscale divided<br /><br>by the number of items per subscale. The total score is calculated as the mean<br /><br>of all items, where a higher score indicates greater heart-focussed anxiety.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>• LEC-5 to obtain information about previous traumatic life events which can<br /><br>affect their anxiety levels and sensitivity for the EMDR treatment;<br /><br>• PTSD Check-List (PLC-5) to examine PTSD symptoms;<br /><br>• General Anxiety Questionnaire (GAD-7) to examine general anxiety symptoms.<br /><br>• Patient Health Questionnaire (PHQ-9) to examine depression symptoms;<br /><br>• EuroQol (EQ5D-5L) to examine quality of life.</p><br>
© Copyright 2025. All Rights Reserved by MedPath